Obstetrics and Gynecology

1046 soru

Soru 961Soru →

A 2424-year-old primigravida at 4141 weeks gestation is undergoing induction of labor for a post-term pregnancy. She is currently 55 cm dilated, 100%100\% effaced, and the fetal presenting part is at 00 station. Artificial rupture of membranes was performed one hour ago, releasing a small amount of clear fluid. Uterine contractions are occurring every 33 minutes. The fetal heart rate tracing demonstrates a baseline of 135135/min with moderate variability. However, with nearly every contraction, there is an abrupt decrease in the fetal heart rate to 7070 to 8080/min that lasts for 4040 to 5050 seconds before rapidly returning to the baseline. The patient's vital signs include a blood pressure of 118/76118/76 mmHg, a heart rate of 9292/min, and a respiratory rate of 2222/min. She reports intense pain during contractions. The nursing staff has already changed the patient's position and administered an intravenous fluid bolus, but the abnormal fetal heart rate pattern persists. Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Initiation of an amnioinfusion

Cevap

Initiation of an amnioinfusion
The correct answer is the initiation of an amnioinfusion. This patient is exhibiting recurrent variable decelerations, defined as abrupt decreases in the fetal heart rate (onset to nadir of less than 3030 seconds) occurring with greater than 50%50\% of uterine contractions. These decelerations are caused by umbilical cord compression, which is particularly common after the rupture of membranes, in the setting of oligohydramnios, or during a post-term pregnancy. Initial resuscitative measures include maternal repositioning (to shift the fetus and relieve pressure on the cord) and intravenous fluid administration. When these conservative measures fail to resolve the decelerations, the next best step is an amnioinfusion. This procedure involves instilling an isotonic fluid (such as normal saline or lactated Ringer's) directly into the amniotic cavity via an intrauterine pressure catheter. The added fluid creates more space within the uterus, floating the umbilical cord and relieving the compression, which frequently resolves the decelerations and allows vaginal delivery to proceed.

Adım Adım Çözüm

1
Analyze the fetal heart rate tracing to identify the specific abnormality.
The tracing shows abrupt decreases in the fetal heart rate (onset to nadir <30< 30 seconds) associated with contractions, which defines variable decelerations.
Identifying the deceleration type determines the underlying pathophysiology, which in this case is umbilical cord compression.
2
Assess the severity of the decelerations and the response to initial interventions.
The decelerations are recurrent (occurring with ≥50%\geq 50\% of contractions) and severe (dropping to 7070 to 8080/min). They have not resolved with maternal repositioning or intravenous fluids.
Recurrent variable decelerations can lead to fetal hypoxia and acidemia if the cord compression is not relieved, necessitating further intervention.
3
Determine the most appropriate definitive intervention to relieve the compression.
The next step in the treatment algorithm is the instillation of isotonic fluid into the amniotic cavity.
Amnioinfusion increases the amniotic fluid volume, which floats the umbilical cord, reduces compression during contractions, and decreases the need for cesarean delivery.

Anahtar Kavram

Recurrent variable decelerations are managed stepwise: first with maternal repositioning and oxygen/fluids, followed by amnioinfusion if the decelerations persist, to relieve umbilical cord compression.
Soru 962Soru →

Match each clinical presentation of peripartum complications to the most accurate diagnostic etiology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A G2P1 patient at 37 weeks of pregnancy presents with sudden-onset, severe, continuous abdominal pain and dark vaginal bleeding. Examination reveals a rigid, hypertonic uterus.
An otherwise healthy G3P2 patient at 36 weeks of pregnancy reports a sudden episode of painless, bright red vaginal bleeding. Her abdomen is soft and non-tender.
A G4P3 patient at 39 weeks of pregnancy with a history of a prior classical cesarean delivery experiences sudden tearing abdominal pain, followed by an immediate upward shift in fetal station.
A G1P0 patient at 38 weeks of pregnancy undergoes artificial rupture of membranes, which is immediately followed by a gush of blood-tinged vaginal fluid and acute, sustained fetal bradycardia.
A G1P0 patient at 39 weeks of pregnancy experiences sudden, profound cardiovascular collapse and hypoxemic respiratory failure immediately following a prolonged vaginal delivery.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

1 matches with Placental abruption, 2 matches with Placenta previa, 3 matches with Uterine rupture, 4 matches with Vasa previa, and 5 matches with Amniotic fluid embolism.
Each clinical vignette provides classic pathognomonic signs for distinct obstetric emergencies. Painful bleeding with a firm uterus indicates placental abruption. Painless bleeding with a soft uterus indicates placenta previa. Sudden loss of fetal station with a prior classical incision indicates uterine rupture. Bleeding and fetal bradycardia post-amniotomy indicate vasa previa. Immediate postpartum cardiovascular collapse indicates an amniotic fluid embolism.

Adım Adım Çözüm

1
Analyze the first presentation: painful bleeding and a rigid uterus.
Identified as placental abruption.
The separation of the placenta causes retroplacental hemorrhage, leading to uterine irritability, tetany, and severe pain.
2
Analyze the second presentation: painless, bright red bleeding.
Identified as placenta previa.
The placenta covers the cervical os; as the lower uterine segment changes, painless maternal bleeding occurs.
3
Analyze the third presentation: prior classical cesarean, sudden pain, and loss of fetal station.
Identified as uterine rupture.
A classical cesarean scar has a high risk of rupture, causing the fetus to be extruded into the abdomen (demonstrated by the loss of station).
4
Analyze the fourth presentation: bleeding and fetal bradycardia immediately post-amniotomy.
Identified as vasa previa.
Amniotomy directly ruptures unprotected fetal vessels crossing the os, leading to rapid fetal exsanguination and immediate bradycardia.
5
Analyze the fifth presentation: sudden postpartum cardiovascular collapse.
Identified as amniotic fluid embolism.
Amniotic fluid entering the maternal circulation causes a massive anaphylactoid reaction, right heart failure, and often disseminated intravascular coagulation.

Anahtar Kavram

Clinical differentiation of severe obstetric complications based on pain, timing of bleeding, fetal heart rate changes, and maternal vital signs.
Soru 963Soru →

A 62-year-old female presents to the physician reporting two episodes of scant, brownish vaginal discharge over the past month. She achieved menopause at age 51. Her past medical history is notable for colon cancer treated with a right hemicolectomy at age 48, and genetic testing at that time confirmed an MLH1MLH1 gene mutation. She currently takes no daily medications. On pelvic examination, the external genitalia and vagina appear pale with loss of rugae. The cervix is flush with the vaginal vault and appears visually normal. A transvaginal ultrasound is performed in the office, revealing a homogeneous endometrial echo complex measuring 33 mm in thickness, with normal-appearing bilateral ovaries. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Endometrial tissue sampling

Cevap

Endometrial tissue sampling
The correct answer is to perform an in-office sampling of the uterine lining. This patient has postmenopausal bleeding and a known MLH1MLH1 mutation, diagnostic of Lynch syndrome (hereditary nonpolyposis colorectal cancer). Women with Lynch syndrome have a 40% to 60% lifetime risk of developing endometrial cancer. In the general population, a transvaginal ultrasound showing an endometrial thickness of ≤4\leq 4 mm has a greater than 99% negative predictive value for endometrial cancer, and observation is appropriate. However, standard ultrasound thresholds are not adequately sensitive to rule out malignancy in patients with Lynch syndrome or those at risk for type II (non-estrogen dependent) endometrial cancers. Therefore, any postmenopausal bleeding in this high-risk population mandates immediate histologic evaluation, regardless of reassuring sonographic findings.

Adım Adım Çözüm

1
Identify the patient's primary presenting symptom and medical history.
The patient has postmenopausal bleeding (brownish vaginal discharge) and a confirmed MLH1MLH1 gene mutation, indicating Lynch syndrome.
Recognizing the underlying genetic syndrome is critical for determining the appropriate diagnostic pathway, as it drastically alters cancer risk.
2
Evaluate the transvaginal ultrasound findings in the context of her specific risk profile.
The endometrial thickness is 33 mm. While a thickness of ≤4\leq 4 mm is reassuring in the general population, it is not sufficient to rule out malignancy in a patient with Lynch syndrome.
Patients with Lynch syndrome or those at risk for type II endometrial cancers can present with a thin endometrial stripe, rendering standard ultrasound cutoffs unreliable.
3
Determine the definitive next step to rule out endometrial carcinoma.
Histologic evaluation via in-office tissue sampling of the endometrium must be performed.
Tissue diagnosis is the only definitive way to rule out endometrial malignancy in patients where ultrasound cannot be reliably used for triage.

Anahtar Kavram

Patients with Lynch syndrome presenting with postmenopausal bleeding require direct histologic evaluation of the endometrium, as transvaginal ultrasound is not reliably sensitive to rule out malignancy in this high-risk population.
Tahmini Süre:1m 15s
Soru 964Soru →

Pharmacotherapy and targeted interventions are mainstays in the management of various pelvic floor disorders, including overactive bladder, urgency urinary incontinence, and neurogenic bladder. Match each pharmacological agent or intervention with its most critical clinical contraindication or adverse effect profile.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Mirabegron
Oxybutynin
Bethanechol
Intradetrusor OnabotulinumtoxinA

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

Mirabegron matches with severe hypertension contraindication; Oxybutynin matches with narrow-angle glaucoma and dementia; Bethanechol matches with active asthma and bradycardia; Intradetrusor OnabotulinumtoxinA matches with the risk of postoperative incomplete bladder emptying.
Each agent targets a specific aspect of bladder neurophysiology. Beta-3 agonists (mirabegron) cause sympathetic activation; antimuscarinics (oxybutynin) block parasympathetic pathways; cholinergic agonists (bethanechol) stimulate parasympathetic pathways; and botulinum toxin directly paralyzes the detrusor muscle. The adverse effect profile of each intervention is a direct result of these respective mechanisms.

Adım Adım Çözüm

1
Identify the primary mechanism of action for each therapeutic agent.
Mirabegron is a beta-3 agonist; Oxybutynin is an anticholinergic; Bethanechol is a cholinergic agonist; OnabotulinumtoxinA is a neurotoxin blocking acetylcholine release.
Understanding the receptor targets (adrenergic vs. cholinergic) is required to predict systemic effects.
2
Correlate each mechanism of action with its downstream systemic physiological effects.
Beta-3 agonists increase sympathetic tone; anticholinergics decrease parasympathetic tone (drying, pupillary dilation); cholinergic agonists increase parasympathetic tone (secretions, bronchoconstriction); botulinum toxin causes flaccid paralysis.
Systemic physiological changes dictate the specific contraindications for each medication.
3
Map the physiological effects to the specific clinical contraindications provided.
Sympathetic tone links to hypertension (Mirabegron); pupillary dilation links to glaucoma (Oxybutynin); parasympathetic tone links to asthma (Bethanechol); flaccid paralysis links to urinary retention (OnabotulinumtoxinA).
This confirms the correct clinical pairing for each therapeutic intervention.

Anahtar Kavram

Pharmacological management of urinary incontinence requires careful patient selection based on medication mechanisms and their predictable systemic side effect profiles (anticholinergic effects, adrenergic stimulation, or targeted muscle paralysis).
Soru 965Soru →

For each patient scenario involving a potential or confirmed gynecologic malignancy, select the most appropriate evidence-based next step in clinical management.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 55-year-old postmenopausal woman with atypical glandular cells (AGC) on a routine cervical cytology screening.
A 32-year-old nulligravid woman with CIN III and positive endocervical margins following a LEEP procedure who strongly desires future fertility.
A 66-year-old woman presenting with new-onset ascites, early satiety, and a 9-cm complex solid-cystic adnexal mass with nodularity.
A 26-year-old primigravida at 18 weeks gestation with a routine cervical cytology test demonstrating high-grade squamous intraepithelial lesion (HSIL).
A 48-year-old woman presenting with postcoital bleeding and a 4-cm visible, friable cervical mass confirmed as invasive squamous cell carcinoma on punch biopsy.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches align specific gynecologic oncology presentations with their guideline-directed clinical, diagnostic, or surgical interventions.
Each correct pair reflects ACOG and SGO standards of care. AGC requires comprehensive upper and lower genital tract sampling. Positive CIN III margins in a fertility-sparing context require re-excision. Suspected advanced ovarian cancer mandates primary surgical staging without prior biopsy. Pregnant patients with severe dysplasia undergo colposcopy without invasive endocervical sampling. Finally, bulky cervical cancer requires thorough imaging to triage between surgery and chemoradiation.

Adım Adım Çözüm

1
Analyze the patient's age and reproductive status (e.g., postmenopausal, pregnant, desiring fertility).
Determines the safety and appropriateness of specific procedures like endometrial biopsy or endocervical curettage.
Certain procedures are contraindicated during pregnancy, while fertility preservation modifies surgical planning.
2
Evaluate the specific cytology, pathology, or physical exam findings.
Identifies the core clinical problem: AGC, HSIL, CIN III margins, suspected advanced ovarian cancer, or bulky cervical cancer.
Each abnormality has a distinct algorithm in gynecologic oncology guidelines.
3
Select the definitive next step in management based on oncologic principles.
Matches are made to the most evidence-based intervention, balancing diagnostic accuracy with patient safety and definitive treatment.
Standardizing care prevents under-treatment of occult malignancies and avoids iatrogenic harm.

Anahtar Kavram

Guideline-directed diagnostic algorithms and management strategies for gynecologic neoplasia.
Soru 966Soru →

A 31-year-old gravida 4, para 3 at 39 weeks of gestation delivers a 4300-g neonate via spontaneous vaginal delivery. Five minutes after the delivery of an intact placenta, she develops profuse vaginal bleeding. The uterus is palpated as soft and boggy at the level of the umbilicus. Her blood pressure is 95/55 mm Hg, and her pulse is 115/min. Bimanual uterine massage is performed, and a rapid intravenous infusion of oxytocin is started, but the hemorrhage persists. Assuming each subsequent step fails to arrest the bleeding, arrange the following management interventions in the correct chronological sequence from first to last.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: Administration of second-line uterotonics, followed by intrauterine balloon tamponade, then laparotomy with uterine compression sutures, and finally total hysterectomy.
The management of postpartum hemorrhage due to uterine atony follows a stepwise escalation protocol from least to most invasive. After initial uterine massage and oxytocin infusion fail, the immediate next step is to administer second-line medical therapies (such as carboprost, methylergonovine, or misoprostol) alongside tranexamic acid. If medical management is insufficient, the next least invasive intervention is mechanical compression using an intrauterine balloon tamponade. When both nonsurgical and minimally invasive measures fail, a laparotomy is indicated for fertility-sparing surgical techniques, such as B-Lynch compression sutures or stepwise vessel ligation. Finally, if all fertility-sparing measures are exhausted and life-threatening hemorrhage persists, a total hysterectomy is the definitive, life-saving intervention.

Adım Adım Çözüm

1
Evaluate the patient's initial response to standard first-line therapies.
The patient continues to hemorrhage despite bimanual massage and oxytocin, indicating refractory uterine atony.
Identifying the failure of first-line therapy establishes the immediate need to initiate the postpartum hemorrhage escalation algorithm.
2
Identify the next indicated medical intervention.
Administration of second-line uterotonics and tranexamic acid is selected as the first step.
Additional medical therapy must be fully utilized before proceeding to mechanical or surgical interventions.
3
Determine the appropriate minimally invasive mechanical intervention.
Placement of an intrauterine balloon tamponade is chosen as the second step.
If medications fail, mechanical compression provides a non-surgical method to arrest bleeding and should precede invasive laparotomy.
4
Sequence the surgical interventions for intractable cases.
Laparotomy with fertility-sparing compression sutures precedes total hysterectomy.
Fertility-sparing surgeries should always be exhausted prior to performing a definitive, irreversible hysterectomy, which is strictly a life-saving last resort.

Anahtar Kavram

The management of refractory postpartum hemorrhage due to uterine atony requires a stepwise escalation from medical therapies to mechanical tamponade, followed by fertility-sparing surgical techniques, and ultimately definitive hysterectomy.
Soru 967Soru →

Pair the following maternal and fetal clinical presentations with the correct obstetric complication.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A 28-year-old G3P2 at 39 weeks gestation with a prior classical cesarean delivery suddenly experiences severe abdominal pain, loss of fetal station, and abrupt cessation of uterine contractions.
A 35-year-old G2P1 at 36 weeks gestation with chronic hypertension presents with acute-onset intense abdominal pain, dark red vaginal bleeding, and a continuously firm, tender uterus.
A 30-year-old G4P3 at 35 weeks gestation presents with a sudden episode of painless, bright red vaginal bleeding that began while resting, accompanied by reassuring fetal heart tones.
A 26-year-old G1P0 at 38 weeks gestation with a known velamentous cord insertion experiences sudden vaginal bleeding and profound fetal bradycardia immediately after spontaneous membrane rupture.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentation with a prior classical cesarean, loss of fetal station, and cessation of contractions corresponds to Uterine rupture. The presentation with chronic hypertension, intense abdominal pain, and a firm uterus corresponds to Abruptio placentae. The presentation with painless, bright red vaginal bleeding while resting corresponds to Placenta previa. The presentation with velamentous cord insertion and profound fetal bradycardia after membrane rupture corresponds to Vasa previa.
Each clinical vignette contains hallmark features of a specific obstetric emergency. Uterine rupture is characterized by a loss of fetal station and cessation of contractions, especially in patients with prior uterine surgery. Abruptio placentae presents with painful, dark vaginal bleeding and a rigid uterus, strongly associated with maternal hypertension. Placenta previa is the classic cause of painless, bright red third-trimester bleeding. Vasa previa uniquely presents with painless bleeding and immediate fetal distress (bradycardia) occurring precisely at the time of amniotomy or spontaneous membrane rupture.

Adım Adım Çözüm

1
Analyze the first clinical vignette to identify key pathognomonic signs.
Identified classic signs of uterine rupture: prior classical cesarean, sudden severe pain, loss of fetal station, and cessation of contractions.
These signs point directly to full-thickness disruption of the myometrium with extrusion of fetal parts.
2
Evaluate the second presentation focusing on maternal risk factors and uterine physical exam findings.
Identified abruptio placentae based on chronic hypertension, sudden severe pain, dark bleeding, and a hypertonic, tender uterus.
Hypertension is a major risk factor for premature placental separation, leading to concealed or revealed hemorrhage with tetanic uterine contractions.
3
Assess the third scenario's bleeding characteristics and fetal status.
Diagnosed placenta previa due to the sudden onset of painless, bright red vaginal bleeding in the third trimester with reassuring fetal status.
Placental tissue overlying the cervical os can bleed painlessly as the lower uterine segment changes, without causing immediate uterine hypertonus.
4
Correlate the fourth patient's membrane rupture event with the immediate fetal heart rate changes.
Recognized vasa previa rupture based on the velamentous cord insertion, immediate bleeding upon membrane rupture, and profound fetal bradycardia.
Rupture of fetal vessels causes rapid fetal exsanguination, immediately reflected as severe fetal bradycardia.

Anahtar Kavram

Differentiating third-trimester bleeding and obstetric emergencies relies on evaluating pain, uterine tone, maternal risk factors, and fetal heart rate patterns.
Soru 968Soru →

A 32-year-old pregnant patient, gravida 2, para 1, presents to the obstetric triage unit at 38 weeks gestation reporting painful uterine contractions. The pregnancy has been notable for an anatomy ultrasound at 20 weeks showing a succenturiate placental lobe. Her temperature is 37.0 C (98.6 F), blood pressure is 112/70 mm Hg, and pulse is 86/min. The initial fetal heart rate baseline is 145/min with moderate variability and no decelerations. Cervical examination shows 5 cm dilation and intact membranes. Three hours into her admission, the patient experiences spontaneous rupture of membranes, accompanied by a moderate amount of bright red vaginal bleeding. Immediately following this event, the fetal heart rate tracing demonstrates a prolonged deceleration that evolves into a sinusoidal pattern with a baseline of 90/min. Uterine resting tone is normal, and contractions are occurring every 3 minutes. Which of the following is the most appropriate next step in management of this patient?

Cevabı ve açıklamayı göster

Cevap: Immediate cesarean delivery

Cevap

Immediate cesarean delivery
The correct answer is immediate cesarean delivery because the clinical presentation is highly specific for a ruptured vasa previa. A succenturiate (accessory) placental lobe is a major risk factor for vasa previa, a condition where fetal blood vessels traverse the amniotic membranes across the lower uterine segment. When the membranes rupture, these unprotected fetal vessels can tear, leading to rapid fetal exsanguination. This is clinically identified by the triad of spontaneous rupture of membranes, painless vaginal bleeding, and immediate, profound fetal distress. The fetal heart rate typically shows a prolonged deceleration, bradycardia, or a sinusoidal pattern (the classic sign of severe fetal anemia). Because the fetal blood volume is extremely small, even minor vessel bleeding can be catastrophic, making emergent surgical delivery the only viable intervention.

Adım Adım Çözüm

1
Identify the patient's anatomic risk factor
The patient has a succenturiate placental lobe.
This structural anomaly predisposes to vasa previa because unprotected fetal vessels often traverse the amniotic membranes between the main placenta and the accessory lobe.
2
Evaluate the acute clinical change during labor
Spontaneous rupture of membranes is immediately followed by bright red bleeding and a severe fetal heart rate decompensation (prolonged deceleration evolving into a sinusoidal pattern).
These findings represent the classic triad of ruptured vasa previa, leading to rapid fetal exsanguination and hypovolemic shock.
3
Determine the definitive next best step in management
The patient requires immediate surgical intervention.
Due to the small total blood volume of a fetus, ruptured vasa previa is a catastrophic event. Emergent cesarean delivery is the only intervention that can prevent fetal demise.

Anahtar Kavram

Vasa previa classically presents with painless vaginal bleeding and profound fetal distress (such as a prolonged deceleration, bradycardia, or sinusoidal pattern) immediately following rupture of membranes, requiring emergent cesarean delivery.
Soru 969Soru →

A 48-year-old woman comes to the clinic reporting a 3-week history of constant, small-volume urine leakage. She states that she never experiences a sudden urge to void, nor does the leakage worsen exclusively with coughing or laughing. However, she frequently feels that her bladder is full and reports a weak, hesitant urinary stream. The patient was diagnosed with multiple sclerosis five years ago and has had two prior exacerbations involving lower extremity weakness. Vital signs are within normal limits. Abdominal examination reveals a palpable, non-tender suprapubic mass. Neurologic examination shows symmetrically increased deep tendon reflexes in the lower extremities. Urinalysis is negative for leukocyte esterase and nitrites. A bladder ultrasound demonstrates a post-void residual volume of 450 mL.

Which of the following is the most appropriate next step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Intermittent urethral catheterization

Cevap

Intermittent urethral catheterization is the correct management for overflow incontinence due to a neurogenic bladder.
This patient's presentation of constant, small-volume urinary leakage, a palpable suprapubic mass, a weak stream, and a markedly elevated post-void residual (PVR) volume of 450 mL is diagnostic of overflow incontinence. In the setting of multiple sclerosis, this is likely due to a neurogenic bladder (e.g., detrusor sphincter dyssynergia or detrusor areflexia). The initial management of non-obstructive overflow incontinence requires bladder decompression to prevent progressive renal damage and recurrent infections. Intermittent urethral catheterization is the preferred first-line therapy.

Adım Adım Çözüm

1
Analyze the patient's presentation and history.
The patient has continuous, small-volume leakage, a palpable suprapubic mass, a weak urinary stream, and a history of multiple sclerosis.
Identifying the pattern of leakage and underlying comorbidities is essential for categorizing the type of urinary incontinence.
2
Evaluate the diagnostic findings.
The urinalysis is normal, ruling out infection. The post-void residual (PVR) volume is 450 mL (markedly elevated).
A PVR greater than 150-200 mL confirms urinary retention, pointing to overflow incontinence.
3
Determine the appropriate management.
The primary goal is bladder decompression via intermittent urethral catheterization.
In overflow incontinence caused by detrusor underactivity or sphincter dyssynergia (common in MS), intermittent catheterization safely empties the bladder, preventing upper urinary tract damage.

Anahtar Kavram

Overflow incontinence presents with continuous urinary leakage, a palpable bladder, and a high post-void residual volume, and is best managed initially with intermittent urethral catheterization.
Soru 970Soru →

A 68-year-old woman is brought to the clinic for evaluation of blood-tinged vaginal discharge that started 3 weeks ago. She attained menopause at age 52. Her medical history is significant for hypertension, obesity, and estrogen receptor-positive breast cancer diagnosed 3 years ago, for which she was treated with a lumpectomy and radiation therapy. She is currently taking tamoxifen. Pelvic examination reveals a small amount of dark blood in the vaginal vault. The cervix appears flush with the vagina and is severely stenotic. A transvaginal ultrasound shows an endometrial thickness of 14 mm with multiple small cystic spaces. An attempt to perform an in-office endometrial biopsy is unsuccessful because the sampling device cannot pass through the external cervical os, despite the use of a tenaculum and misoprostol preparation. Which of the following is the most appropriate next step in management?

Cevabı ve açıklamayı göster

Cevap: Hysteroscopy with dilation and curettage

Cevap

Hysteroscopy with dilation and curettage
This patient presents with postmenopausal bleeding and a significantly thickened endometrium while on tamoxifen, raising high clinical suspicion for endometrial hyperplasia or carcinoma. Although tamoxifen classically causes benign cystic changes in the endometrium, any vaginal bleeding in a postmenopausal woman requires a definitive tissue diagnosis. Because an in-office endometrial biopsy cannot be completed due to severe cervical stenosis, the next most appropriate step is hysteroscopy with dilation and curettage (D&C) under anesthesia. This approach allows for mechanical dilation of the stenotic os, direct visualization of the uterine cavity to rule out focal lesions like polyps, and comprehensive tissue sampling.

Adım Adım Çözüm

1
Identify the primary clinical problem and the patient's risk factors.
The patient has postmenopausal bleeding with significant risk factors for endometrial cancer, including advanced age, obesity, and tamoxifen use.
Recognizing these high-risk features highlights the urgency of ruling out malignancy.
2
Interpret the diagnostic imaging findings in the context of the patient's history.
Transvaginal ultrasound shows a thickened endometrium (14 mm). Although subendometrial cystic spaces are characteristic of tamoxifen-induced changes, they do not exclude cancer.
Ultrasound findings cannot replace tissue histology when abnormal bleeding is present.
3
Assess the outcome of the initial diagnostic procedure.
The indicated in-office endometrial biopsy failed due to severe cervical stenosis.
An adequate tissue sample has not yet been obtained, leaving the diagnostic workup incomplete.
4
Select the appropriate alternative diagnostic modality.
Hysteroscopy with dilation and curettage is selected to safely dilate the cervix under anesthesia, directly visualize the cavity, and obtain the necessary tissue.
It is the standard, definitive secondary approach for a failed office endometrial sampling.

Anahtar Kavram

In postmenopausal women with vaginal bleeding, a failed in-office endometrial sampling (often due to cervical stenosis) necessitates further evaluation via hysteroscopy with dilation and curettage to definitively rule out endometrial carcinoma.
Soru 971Soru →

A 16-year-old girl is brought to the clinic for evaluation of absent menarche. Her medical history is unremarkable. She is at the 10th percentile for height and 50th percentile for weight. Physical examination reveals absent breast development (Tanner stage I) and normal external female genitalia. Arrange the following diagnostic and therapeutic steps in the most appropriate chronological sequence for the evaluation and management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct sequence is: Pelvic ultrasound -> Serum FSH measurement -> Karyotype analysis -> Identification of 45,X -> Initiation of estrogen therapy.
The standard evaluation of primary amenorrhea begins with a physical examination and pelvic ultrasound. The ultrasound determines the presence or absence of a uterus, which bifurcates the diagnostic algorithm. Since a uterus is present, the next step is to measure serum FSH to evaluate the hypothalamic-pituitary-ovarian axis. An elevated FSH level indicates primary ovarian insufficiency (hypergonadotropic hypogonadism). The most common cause of this in a 16-year-old is a chromosomal abnormality, necessitating a karyotype. Once Turner syndrome (45,X) is diagnosed definitively, estrogen therapy is initiated to stimulate pubertal development and protect bone density.

Adım Adım Çözüm

1
Determine the anatomical status of the internal genitalia.
Pelvic ultrasound confirms the presence of a uterus.
Müllerian agenesis and androgen insensitivity syndrome present with an absent uterus. Confirming its presence narrows the differential diagnosis to gonadal or central causes.
2
Assess the hypothalamic-pituitary-ovarian axis.
Measurement of serum FSH reveals elevated levels (hypergonadotropic hypogonadism).
Elevated FSH indicates primary ovarian insufficiency (lack of negative feedback from estrogen), while low or normal FSH points to a central (hypothalamic/pituitary) defect.
3
Investigate the cause of primary ovarian insufficiency.
Peripheral blood karyotype analysis is ordered and reveals a 45,X complement.
Chromosomal abnormalities (e.g., Turner syndrome, Swyer syndrome) are the most common cause of primary ovarian insufficiency in young patients presenting with primary amenorrhea.
4
Implement appropriate medical management based on the diagnosis.
Low-dose estrogen therapy is initiated.
Patients with Turner syndrome lack endogenous estrogen production. Exogenous estrogen is required to induce pubertal development and ensure proper bone mineralization.

Anahtar Kavram

The evaluation of primary amenorrhea begins with a pelvic ultrasound to confirm the presence of a uterus, followed by FSH measurement to distinguish between central and peripheral causes, and culminates in a karyotype if primary ovarian insufficiency is identified.
Tahmini Süre:1m 30s
Soru 972Soru →

An 18-year-old college student presents to the emergency department complaining of progressive pelvic heaviness and a sudden exacerbation of sharp right lower abdominal pain that began 12 hours ago. A transabdominal ultrasound demonstrates a 14-cm complex right ovarian mass featuring prominent solid components. Her urine pregnancy test is negative. Arrange the following interventions in the most appropriate chronological sequence for the standard diagnostic workup and definitive management of this patient.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct chronological sequence is: 1) Draw serum tumor markers, 2) Perform unilateral salpingo-oophorectomy with intraoperative frozen section, 3) Complete surgical staging if malignant, 4) Review final permanent histopathology, and 5) Initiate adjuvant BEP chemotherapy.
The standard of care for a young female with a suspicious complex adnexal mass prioritizes both fertility preservation and accurate oncologic staging. Preoperative tumor markers (AFP, LDH, hCG) are an essential first step for diagnosis and establishing a baseline for future surveillance. Surgery must begin with a fertility-sparing unilateral salpingo-oophorectomy and an immediate intraoperative frozen section. If malignancy is confirmed, the surgeon proceeds immediately to comprehensive staging (washings, omental biopsy, lymph node sampling) during the same operation to avoid a second surgery. Postoperatively, the final permanent pathology dictates the adjuvant plan, which typically consists of multi-agent BEP chemotherapy for malignant germ cell tumors.

Adım Adım Çözüm

1
Obtain serum tumor markers (AFP, LDH, hCG).
Establishes a biochemical baseline prior to surgical manipulation.
Crucial for diagnosing specific germ cell tumors in young women and providing an indispensable baseline for monitoring therapeutic response and disease recurrence.
2
Perform unilateral salpingo-oophorectomy and obtain a frozen section.
Safely removes the primary tumor while preserving the contralateral ovary and uterus.
Fertility preservation is paramount in young patients. The intraoperative frozen section dictates whether the surgeon must proceed to more extensive staging procedures.
3
Complete comprehensive surgical staging.
Obtains peritoneal fluid, omental tissue, and lymph nodes for microscopic evaluation.
Required to determine the anatomical spread of the disease (FIGO stage) only if the intraoperative frozen section confirms a malignancy.
4
Review final permanent pathology.
Provides the precise histological subtype and formal formal surgical stage.
Permanent sections overcome the limitations of frozen sections (e.g., identifying mixed germ cell components) and definitively guide the necessity for adjuvant treatment.
5
Administer adjuvant BEP chemotherapy.
Eradicates microscopic residual disease.
Germ cell tumors are highly chemosensitive, and multi-agent chemotherapy is the standard of care following surgery to ensure long-term survival and cure in advanced or aggressive subtypes.

Anahtar Kavram

Management sequence of suspected ovarian germ cell tumors prioritizes preoperative tumor markers, fertility-sparing surgery with intraoperative frozen section, immediate surgical staging if malignant, and tailored adjuvant chemotherapy.
Soru 973Soru →

A multiparous patient in her late fifties reports involuntary loss of urine that occurs exclusively when she sneezes, coughs, or participates in high-impact aerobics. Physical examination confirms the diagnosis without evidence of concurrent urgency symptoms or significant pelvic organ prolapse. According to standard urogynecologic protocols for this specific condition, arrange the following therapeutic interventions in the correct order of clinical escalation, starting with the least invasive initial recommendation and progressing to definitive surgical treatments.

Öğeleri doğru sıraya koymak için sürükleyin

Cevabı ve açıklamayı göster

Cevap

The correct stepwise management for stress urinary incontinence escalates from pelvic floor muscle training, to an incontinence pessary, then to a synthetic midurethral sling, and finally to an autologous fascial sling for complex cases.
The standard treatment algorithm for stress urinary incontinence prioritizes patient safety and escalates invasiveness only when clinically necessary. Pelvic floor muscle training (PFMT) is the safest initial step and serves as the universal first-line therapy. For patients seeking additional non-surgical control, an incontinence pessary is the next logical progression. If the patient desires definitive treatment or fails conservative measures, a synthetic midurethral sling is the gold-standard primary surgical intervention. Finally, for complex cases such as those failing a synthetic sling or presenting with mesh contraindications, an autologous fascial sling is utilized as an advanced surgical escalation.

Adım Adım Çözüm

1
Diagnose the underlying type of incontinence based on the clinical history.
The presentation of leakage exclusively with increased intra-abdominal pressure indicates pure stress urinary incontinence (SUI).
Identifying the correct incontinence type is essential because SUI and urgency incontinence have completely different treatment algorithms.
2
Identify the first-line conservative management.
Pelvic floor muscle rehabilitation.
Non-invasive physical therapy is always the starting point for SUI management.
3
Identify the non-surgical mechanical option.
Vaginal incontinence pessary.
A pessary provides mechanical urethral support without exposing the patient to surgical risks.
4
Determine the correct surgical escalation.
Synthetic midurethral sling, followed by an autologous fascial sling if refractory.
Synthetic slings are the primary standard-of-care surgery, while autologous slings are reserved for complex or mesh-contraindicated cases.

Anahtar Kavram

The management of stress urinary incontinence escalates stepwise from conservative pelvic floor muscle training, to non-surgical mechanical support, to primary surgery (midurethral sling), and finally to complex reconstructive surgery (autologous sling).
Soru 974Soru →

A 3131-year-old woman, gravida 00, presents to the clinic for evaluation of a 1414-month history of inability to conceive. The patient and her partner have been engaging in regular, unprotected intercourse. Menarche occurred at age 1212. Her menses were previously regular, occurring every 2828 days, but over the past year, they have become irregular, occurring every 4545 to 6060 days. The patient has also noticed new, coarse dark hairs on her chin and upper lip. She reports feeling unusually fatigued recently, which she attributes to stress at her job, and has gained 6 kg6 \text{ kg} (13.2 lbs13.2 \text{ lbs}) over the past 66 months despite no changes in her diet.

Vital signs show a temperature of 36.6∘C36.6^\circ\text{C} (97.9∘F97.9^\circ\text{F}), blood pressure of 112/74 mmHg112/74 \text{ mmHg}, and heart rate of 58/min58\text{/min}. Her body mass index (BMI) is 32 kg/m232 \text{ kg/m}^2. Physical examination reveals coarse facial hair and dry skin. Pelvic examination is unremarkable.

Laboratory evaluation reveals the following:

Follicle-stimulating hormone (FSH): 5 mIU/mL5 \text{ mIU/mL}
Luteinizing hormone (LH): 6 mIU/mL6 \text{ mIU/mL}
Prolactin: 48 ng/mL48 \text{ ng/mL} (Normal: <20 ng/mL<20 \text{ ng/mL})
Thyroid-stimulating hormone (TSH): 14.5 \muIU/mL14.5 \text{ \mu IU/mL} (Normal: 0.4−4.0 \muIU/mL0.4-4.0 \text{ \mu IU/mL})
Free thyroxine (T4): 0.6 ng/dL0.6 \text{ ng/dL} (Normal: 0.8−1.8 ng/dL0.8-1.8 \text{ ng/dL})

A urine pregnancy test is negative.

Which of the following is the most appropriate initial management for this patient's inability to conceive?

Cevabı ve açıklamayı göster

Cevap: Levothyroxine

Cevap

Levothyroxine
This patient's infertility, oligomenorrhea, and hirsutism are all downstream effects of untreated primary hypothyroidism. In primary hypothyroidism, decreased negative feedback from low thyroxine (T4) levels leads to increased secretion of thyrotropin-releasing hormone (TRH) from the hypothalamus. TRH serves as a potent stimulator of both thyrotrophs (causing the elevated TSH) and lactotrophs in the anterior pituitary. This lactotroph stimulation results in secondary hyperprolactinemia. Elevated prolactin then disrupts the pulsatile release of gonadotropin-releasing hormone (GnRH), resulting in ovulatory dysfunction and infertility. Furthermore, low levels of circulating thyroid hormone decrease the hepatic synthesis of sex hormone-binding globulin (SHBG). Lower SHBG leads to a higher fraction of free (biologically active) testosterone, which manifests clinically as hirsutism. Treating the root cause with levothyroxine will normalize TRH secretion, subsequently normalizing prolactin levels, restoring regular ovulatory cycles, and increasing SHBG production to improve hyperandrogenic symptoms.

Adım Adım Çözüm

1
Analyze the clinical presentation and laboratory values.
The patient presents with oligomenorrhea, infertility, hirsutism, weight gain, fatigue, and bradycardia. Labs show high TSH and low free T4 (primary hypothyroidism), alongside mildly elevated prolactin.
Identifying all abnormal findings ensures the underlying pathophysiology is correctly recognized rather than prematurely diagnosing based on isolated symptoms.
2
Connect the endocrine axes to explain the constellation of symptoms.
Primary hypothyroidism results in low T4, which decreases negative feedback on the hypothalamus, leading to increased thyrotropin-releasing hormone (TRH) secretion. TRH directly stimulates both thyrotrophs (increasing TSH) and lactotrophs (increasing prolactin).
Understanding that TRH stimulates prolactin release is key to recognizing that the hyperprolactinemia is secondary to the thyroid dysfunction.
3
Determine the mechanism for infertility and hyperandrogenism.
Elevated prolactin inhibits the pulsatile release of GnRH, leading to ovulatory dysfunction and infertility. Additionally, low thyroid hormone levels decrease hepatic synthesis of sex hormone-binding globulin (SHBG), increasing free testosterone and causing hirsutism.
This dual mechanism explains why primary hypothyroidism acts as a profound mimic of polycystic ovary syndrome (PCOS).
4
Select the most appropriate initial management based on the root cause.
Exogenous levothyroxine administration.
Restoring a euthyroid state will suppress TRH, normalizing prolactin levels, restoring ovulatory cycles, and increasing SHBG to resolve the hyperandrogenism.

Anahtar Kavram

Primary hypothyroidism as a systemic cause of secondary hyperprolactinemia, ovulatory dysfunction, and hyperandrogenism (due to decreased SHBG).
Tahmini Süre:1m 30s
Soru 975Soru →

A 27-year-old female patient seeks medical evaluation because she has been unable to conceive for the past year and a half. She notes that her menses are infrequent, occurring only 5 to 6 times per year. She also reports progressive, unwanted hair growth on her face and abdomen over the last four years. She has no other medical conditions and does not take any prescription medications. Her body mass index is 30 kg/m2 and blood pressure is 118/76 mm Hg. On physical examination, terminal hairs are noted on her chin, upper lip, and lower abdomen. No clitoromegaly or purple striae are observed. Transvaginal ultrasonography reveals polycystic morphology in both ovaries. Serum levels of prolactin and thyroid-stimulating hormone are within normal reference ranges. Which of the following is the most appropriate test to perform next to establish the etiology of her symptoms?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum 17-hydroxyprogesterone

Cevap

Measurement of serum 17-hydroxyprogesterone
According to the Rotterdam criteria, the diagnosis of polycystic ovary syndrome (PCOS) requires at least two of the following three features: oligo-ovulation or anovulation, clinical or biochemical signs of hyperandrogenism, and polycystic ovaries on ultrasound. Crucially, other etiologies of hyperandrogenism and menstrual irregularity must be excluded to finalize the diagnosis. Non-classic congenital adrenal hyperplasia (NCCAH), typically caused by a partial 21-hydroxylase deficiency, can present with symptoms identical to PCOS (hirsutism, acne, irregular menses, and polycystic ovaries). Therefore, clinical guidelines mandate measuring a morning, early follicular phase serum 17-hydroxyprogesterone level in all women presenting with suspected PCOS to rule out NCCAH before making a definitive diagnosis.

Adım Adım Çözüm

1
Identify the patient's primary clinical syndrome based on the presentation.
The patient presents with oligo-ovulation (infrequent menses), clinical hyperandrogenism (hirsutism), and polycystic ovaries on ultrasound.
These three findings fulfill the Rotterdam criteria for suspected polycystic ovary syndrome (PCOS), pending the exclusion of other mimicking etiologies.
2
Determine the necessary diagnostic workup to finalize the diagnosis.
Other disorders that mimic PCOS must be formally ruled out. Thyroid disease and hyperprolactinemia have already been excluded with normal laboratory results. The next most critical condition to exclude is non-classic congenital adrenal hyperplasia (NCCAH).
Because PCOS is a diagnosis of exclusion, and NCCAH can present identically to PCOS, it must be excluded by measuring a basal serum 17-hydroxyprogesterone level.

Anahtar Kavram

Polycystic ovary syndrome (PCOS) is a diagnosis of exclusion; patients presenting with hyperandrogenism and irregular menses must have a serum 17-hydroxyprogesterone level checked to rule out non-classic congenital adrenal hyperplasia.
Soru 976Soru →

Concerned by a complete cessation of her menstrual cycles over the past six months, a female in her late twenties visits a specialist. She and her partner have been having regular, unprotected intercourse for the past 14 months without a pregnancy. The patient expresses significant distress regarding a recent, rapid increase in coarse hair growth on her chin, chest, and lower abdomen, as well as a noticeable deepening of her voice. She has no chronic medical conditions and takes no medications. Her blood pressure is 122/78 mmHg, and her body mass index is 24 kg/m². Physical examination reveals temporal hair thinning, severe nodulocystic acne, and prominent clitoromegaly. Bimanual pelvic examination is unremarkable. Transvaginal ultrasonography reveals normal-sized ovaries lacking any cystic changes or solid masses. A urine pregnancy test is negative. Which of the following is the most appropriate next step in the evaluation of this patient?

Cevabı ve açıklamayı göster

Cevap: Measurement of serum testosterone and dehydroepiandrosterone sulfate levels

Cevap

Measurement of serum testosterone and dehydroepiandrosterone sulfate levels
The correct action is to measure serum testosterone and dehydroepiandrosterone sulfate (DHEAS) levels. The patient's rapid-onset virilization (voice deepening, clitoromegaly, temporal thinning) over six months is highly suspicious for an androgen-secreting tumor. Biochemical evaluation is the required next step to localize the source: elevated DHEAS points to an adrenal tumor, while markedly elevated testosterone points to an ovarian tumor.

Adım Adım Çözüm

1
Analyze the patient's clinical presentation and timeline.
The patient has a 6-month history of secondary amenorrhea coupled with rapid-onset, severe hyperandrogenism (hirsutism, acne) and virilization (clitoromegaly, voice deepening, temporal balding).
Differentiating between gradual hyperandrogenism and rapid virilization is the critical branch point in evaluating androgen excess in females.
2
Formulate a differential diagnosis based on the severity and onset.
Rapid-onset virilization is a red flag for an androgen-secreting tumor, differentiating it from benign, gradual conditions like Polycystic Ovary Syndrome (PCOS) or Non-Classic Congenital Adrenal Hyperplasia (NCAH).
Benign conditions rarely cause frank virilization such as clitoromegaly or voice changes in adulthood.
3
Determine the optimal diagnostic sequence for suspected androgen-secreting tumors.
Biochemical testing must precede advanced imaging. Serum testosterone localizes production primarily to the ovaries, while dehydroepiandrosterone sulfate (DHEAS) localizes production to the adrenal glands.
Imaging (like an abdominal CT) without biochemical guidance may result in unnecessary radiation or miss small, occult ovarian tumors that require surgical exploration or specialized pelvic MRI.

Anahtar Kavram

Evaluation of rapid-onset virilization and hyperandrogenism in adult females
Soru 977Soru →

Match each clinical and laboratory presentation of secondary amenorrhea to the most likely underlying etiology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

26-year-old female marathon runner with amenorrhea. Labs: Low FSH, low LH, low estradiol.
32-year-old female with amenorrhea, vaginal dryness, and hot flashes. Labs: Elevated FSH, low estradiol.
29-year-old female with irregular menses, acne, and a BMI of 32. Labs: Elevated LH to FSH ratio, elevated testosterone.
24-year-old female with amenorrhea and bilateral clear nipple discharge. Labs: Low FSH, low estradiol, elevated prolactin.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The presentations map to their respective localizations of the hypothalamic-pituitary-ovarian axis defects based on gonadotropin and estrogen levels.
Secondary amenorrhea evaluation relies on the localization of the physiologic defect. Hypothalamic defects (such as functional hypothalamic amenorrhea) and pituitary defects (such as a prolactinoma) present with low or inappropriately normal FSH and LH levels, known as hypogonadotropic hypogonadism. Ovarian defects (such as primary ovarian insufficiency) present with elevated FSH and LH, known as hypergonadotropic hypogonadism. Polycystic ovary syndrome classically presents with clinical or biochemical hyperandrogenism and an elevated LH to FSH ratio.

Adım Adım Çözüm

1
Analyze the laboratory profile of the 26-year-old marathon runner.
Low gonadotropins and low estradiol indicate a central defect; extreme exercise points to functional hypothalamic amenorrhea.
An extreme energy deficit suppresses the hypothalamic-pituitary-ovarian axis to conserve energy.
2
Evaluate the 32-year-old with hot flashes and elevated FSH.
Elevated FSH and low estradiol indicate a primary ovarian defect, which in a woman under 40 represents primary ovarian insufficiency.
Ovarian failure removes the negative feedback on the pituitary, causing FSH levels to rise significantly.
3
Assess the 29-year-old with acne and elevated LH/testosterone.
Clinical and biochemical hyperandrogenism with oligo-ovulation confirms polycystic ovary syndrome.
Increased LH pulsatility drives ovarian theca cells to overproduce androgens.
4
Examine the 24-year-old with galactorrhea and elevated prolactin.
Hyperprolactinemia, likely from a pituitary microadenoma, suppresses GnRH leading to hypogonadotropic hypogonadism.
Prolactin negatively regulates hypothalamic GnRH release, stopping the menstrual cycle.

Anahtar Kavram

The underlying pathophysiology of secondary amenorrhea can be differentiated by localizing the defect in the hypothalamic-pituitary-ovarian axis using serum FSH, LH, estradiol, and prolactin levels.
Tahmini Süre:2m 0s
Soru 978Soru →

Match each of the following clinical scenarios describing patients presenting for fertility evaluation to the most appropriate primary therapeutic intervention or assisted reproductive technology.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

A patient with a body mass index of 33 kg/m², oligomenorrhea, and clinical hyperandrogenism who has patent fallopian tubes and a partner with normal semen parameters.
A patient with regular menstrual cycles and a history of recurrent pelvic inflammatory disease leading to bilateral distal tubal occlusion, whose partner has normal semen parameters.
A patient with normal ovulation and pelvic anatomy whose partner's semen analysis reveals a concentration of 1.5 million/mL, 15% progressive motility, and 2% normal morphology.
A patient presenting with a 14-month history of secondary amenorrhea, vasomotor symptoms, and a serum follicle-stimulating hormone level of 78 mIU/mL.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The patient with PCOS should receive letrozole; the patient with tubal occlusion should undergo standard IVF; the patient whose partner has severe male factor infertility should undergo ICSI; and the patient with primary ovarian insufficiency should use donor oocyte IVF.
Therapeutic strategies for infertility are highly specific to the underlying pathology. Ovulation induction is indicated for WHO Group II anovulation (e.g., PCOS). Standard IVF is the primary treatment for uncorrectable tubal factor. ICSI is specifically designed to overcome severe male factor deficits. Donor oocytes are required when the patient's own ovarian reserve is exhausted (e.g., primary ovarian insufficiency).

Adım Adım Çözüm

1
Analyze the etiology of infertility for the first patient.
The combination of obesity, oligomenorrhea, and hyperandrogenism diagnoses Polycystic Ovary Syndrome (PCOS).
Determining that ovulation failure is the sole barrier directs therapy toward ovulation induction.
2
Select the appropriate intervention for PCOS.
Letrozole is matched to the first patient.
Letrozole is the first-line evidence-based medication for ovulation induction in PCOS.
3
Analyze the etiology for the second patient.
The patient has structural tubal factor infertility (bilateral distal occlusion).
Anatomical barriers prevent the natural meeting of sperm and oocyte.
4
Select the appropriate intervention for severe tubal disease.
Standard in vitro fertilization (IVF) is matched to the second patient.
IVF bypasses the fallopian tubes by extracting oocytes, fertilizing them in vitro, and transferring embryos directly into the uterus.
5
Analyze the etiology for the third patient.
The infertility is driven by severe male factor (oligoasthenoteratozoospermia).
Sperm quantity and quality are insufficient for natural fertilization or even standard IVF.
6
Select the appropriate intervention for severe male factor.
Intracytoplasmic sperm injection (ICSI) is matched to the third patient.
ICSI mechanically assists fertilization by injecting a single viable sperm directly into the oocyte.
7
Analyze the etiology for the fourth patient.
Elevated FSH and amenorrhea signify primary ovarian insufficiency.
The ovaries no longer contain a functional follicular reserve.
8
Select the appropriate intervention for depleted ovarian reserve.
In vitro fertilization with donor oocytes is matched to the fourth patient.
Pregnancy requires an exogenous source of healthy oocytes.

Anahtar Kavram

Selecting the most appropriate assisted reproductive technology or pharmacological intervention based on the specific underlying etiology of infertility (PCOS, tubal factor, male factor, or primary ovarian insufficiency).
Tahmini Süre:1m 30s
Soru 979Soru →

A 24-year-old nulliparous woman at 40 weeks gestation is evaluated in the labor and delivery unit due to painful uterine contractions. She has no significant past medical history, and her prenatal care has been routine. On admission, her blood pressure is 118/76 mm Hg and her pulse is 78/min. Cervical examination shows 5 cm dilation and 90% effacement. The fetal head is engaged. A lumbar epidural is placed for pain control. Twenty minutes later, the patient complains of dizziness and nausea. Repeat maternal vital signs show a blood pressure of 82/45 mm Hg and a pulse of 105/min. The continuous fetal monitor displays a baseline heart rate of 125/min, minimal variability, and symmetric decreases in the fetal heart rate that nadir after the peak of the uterine contractions. Uterine contractions are occurring every 3 to 4 minutes and lasting 60 seconds.

Which of the following is the most appropriate initial step in the management of this patient?

Cevabı ve açıklamayı göster

Cevap: Maternal left lateral decubitus positioning and rapid intravenous hydration

Cevap

Maternal left lateral decubitus positioning and rapid intravenous hydration
The correct answer is maternal left lateral decubitus positioning and rapid intravenous hydration. This patient is experiencing late fetal heart rate (FHR) decelerations secondary to maternal hypotension, a common complication of epidural anesthesia. Epidural blocks the sympathetic nervous system, leading to peripheral vasodilation and decreased venous return to the heart. This reduces cardiac output and blood pressure, which in turn decreases uteroplacental perfusion, causing fetal hypoxia and late decelerations. The initial step in management (intrauterine resuscitation) aims to restore maternal blood pressure and placental blood flow. Left lateral decubitus positioning displaces the gravid uterus off the inferior vena cava, enhancing venous return. A rapid intravenous fluid bolus expands intravascular volume. If these initial measures fail, intravenous vasopressors (such as ephedrine or phenylephrine) are indicated.

Adım Adım Çözüm

1
Identify the primary maternal complication.
The patient has developed acute hypotension (82/45 mm Hg) shortly after receiving a lumbar epidural.
Epidural anesthesia frequently causes sympathetic blockade, leading to vasodilation, venous pooling, and subsequent maternal hypotension.
2
Interpret the fetal heart rate (FHR) tracing.
The tracing shows minimal variability and late decelerations (decreases in FHR that nadir after the peak of the contraction).
Maternal hypotension decreases uteroplacental perfusion, leading to transient fetal hypoxia, which classically presents as late decelerations on the FHR monitor.
3
Determine the most appropriate initial step in management.
The correct intervention is intrauterine resuscitation to restore uteroplacental perfusion.
Maternal left lateral decubitus positioning relieves aortocaval compression, increasing venous return. Rapid intravenous hydration expands the intravascular volume, thereby correcting the epidural-induced hypotension and improving placental blood flow.

Anahtar Kavram

Epidural anesthesia can cause maternal hypotension through sympathetic blockade, resulting in decreased uteroplacental perfusion and fetal late decelerations. Initial management includes left lateral positioning and intravenous fluid boluses.
Soru 980Soru →

Match each clinical presentation of an obstetric complication with its most likely diagnosis.

Soldaki öğeye tıklayın, sonra eşleşen sağdaki öğeye tıklayın

Öğeler

Sudden-onset, tearing abdominal pain, abrupt cessation of uterine contractions, and loss of fetal station in a patient with a prior cesarean delivery.
Painless, bright red vaginal bleeding typically noted after sexual intercourse, with a reassuring fetal heart rate tracing.
Painful, dark vaginal bleeding accompanied by a rigid, hypertonic uterus and high-frequency contractions.
Painless vaginal bleeding immediately following spontaneous rupture of membranes, with rapid onset of fetal bradycardia or a sinusoidal heart rate pattern.

Eşleşmeler

Cevabı ve açıklamayı göster

Cevap

The correct matches differentiate the major causes of third-trimester hemorrhage and catastrophic intrapartum events based on the presence of pain, timing of bleeding, and specific fetal or maternal signs.
Each clinical presentation contains pathognomonic features for specific obstetric complications. Placenta previa involves painless maternal bleeding from a placenta overlying the internal os. Placental abruption involves painful bleeding and a rigid uterus due to premature placental detachment. Uterine rupture is characterized by sudden tearing pain, loss of fetal station, and cessation of contractions, usually in a scarred uterus. Vasa previa is marked by painless bleeding exactly at membrane rupture with immediate fetal distress due to fetal exsanguination.

Adım Adım Çözüm

1
Analyze the presence or absence of pain with vaginal bleeding.
Painful bleeding suggests placental abruption or uterine rupture, whereas painless bleeding suggests placenta previa or vasa previa.
Pain is a primary distinguishing factor for the etiology of third-trimester bleeding.
2
Evaluate specific timing and associated features for the painless bleeding presentations.
Bleeding after intercourse points to placenta previa (due to cervical irritation), whereas bleeding exactly at the time of membrane rupture with rapid fetal decline points to vasa previa (due to fetal hemorrhage).
Differentiation of painless bleeding requires looking at inciting events and immediate fetal status.
3
Evaluate associated physical exam findings and history for the painful presentations.
A hypertonic, rigid uterus points to placental abruption, while loss of fetal station and cessation of contractions in a patient with a uterine scar points to uterine rupture.
These distinct signs reflect the underlying pathophysiology of placental separation versus full-thickness myometrial disruption.

Anahtar Kavram

Clinical differentiation of major obstetric hemorrhages (placental abruption, placenta previa, vasa previa, uterine rupture).
ÖncekiSayfa 49 / 53Sonraki
Obstetrics and Gynecology Alıştırma Soruları — USMLE Step 2 CK — Sayfa 49 | Examkin